4 to 10% feldene inicio considerationsPregnancy cat. C, D if used in veterinary medicine to treat certain neoplasias expressing cyclooxygenase (COX) receptors, such as bladder, colon, and prostate cancers.Other brand names for Piroxicam include feldene inicio "Brexin", "Erazon", "Felden", "Feldoral", "Hotemin".

searchPiroxicamSystematic (IUPAC) name(8E)-8-[hydroxy-(pyridin-2-ylamino)methylidene]-9-methyl-10,10-dioxo-10?6-thia-9-azabicyclo[4.4.0]deca-1,3,5-trien-7-oneIdentifiersCAS number 36322-90-4ATC feldene inicio M01AC01 M02AA07, feldene inicio 5280452DrugBank APRD01187Chemical dataFormula C15H13N3O4SMol. mass 331.348 g/molPharmacokinetic dataBioavailability ?Metabolism 4 to 10% renalHalf life 30 to feldene inicio feldene inicio 4 to 10% renalTherapeutic considerationsPregnancy cat. C, D if used in veterinary medicine to treat certain neoplasias expressing cyclooxygenase (COX) receptors, such as bladder, colon, and feldene inicio cancers.Other brand names for Piroxicam include "Brexidol", "Brexin", "Erazon", "Felden", "Feldoral", "Hotemin", "Pirox von ct", "Proponol", "Reumador", "Tracam", "Veral", and "Vurdon".[edit] Mechanism of actionMain article: Non-steroidal anti-inflammatory drugPiroxicam use can result in gastrointestinal toxicity, tinnitus, dizziness, headache, feldene inicio and pruritus. The most severe adverse reactions are peptic ulceration.

bleeding. Approximately 30% of all patients receiving daily doses of 20 mg of piroxicam.